Phase III trials with docetaxel-based combinations for metastatic castration-resistant prostate cancer: time to learn from past experiences

J Clin Oncol. 2013 May 10;31(14):1709-12. doi: 10.1200/JCO.2013.48.8825. Epub 2013 Apr 8.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Humans
  • Male
  • Prostatic Neoplasms / drug therapy*